Home/Filings/4/0001209191-19-023382
4//SEC Filing

NIEMANN BRADLEY V. 4

Accession 0001209191-19-023382

CIK 0000884624other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 5:43 PM ET

Size

12.1 KB

Accession

0001209191-19-023382

Insider Transaction Report

Form 4
Period: 2019-04-01
NIEMANN BRADLEY V.
President Biostim
Transactions
  • Award

    Stock Option (right to buy)

    2019-04-01+11,93911,939 total
    Exercise: $56.20Exp: 2029-04-01Common Stock (11,939 underlying)
  • Award

    Common Stock

    2019-04-01+3,60329,755 total
  • Award

    Common Stock

    2019-04-01+7,40237,157 total
  • Award

    Performance Share Units

    2019-04-01+7,2067,206 total
    Exercise: $0.00Exp: 2022-04-01Common Stock (7,206 underlying)
Footnotes (4)
  • [F1]Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019.
  • [F2]Represents time-based vesting restricted stock units that vest on the second anniversary of the grant date, April 1, 2019.
  • [F3]These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019.
  • [F4]Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2019 to April 1, 2022. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 1, 2019, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.

Issuer

Orthofix Medical Inc.

CIK 0000884624

Entity typeother

Related Parties

1
  • filerCIK 0001669839

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:43 PM ET
Size
12.1 KB